Non-Opioid Pain Treatment Market Size, Share and Forecast 2026
The Non-Opioid Pain Treatment Market was worth $XX million in 2018 and is forecasted to reach $XX million by 2026, at a CAGR of XX% during the forecast period.
(EMAILWIRE.COM, September 13, 2019 ) Market Overview:
Types of pain include chronic headaches, back pain, pain associated with surgery or treatments, sports injuries, and accidents. Every year, millions of prescriptions are written for pain medications, out of which many are powerful opioids that can cause side effects and lead to addiction.
The market is currently gradually inclining towards the adoption of non-opioid medications to overcome the addiction toward opioids and certain well-established painkillers in the market. But there are many non-opioid treatments available for pain such as over-the-counter aspirin, ibuprofen, and acetaminophen, but some of them such as Celebrex, Cataflam, and Motrin, are prescription only drugs.
Market Dynamics:
The market is driven by rising geriatric population, rise in incidences of chronic pain, increase in the opioid misuse, easy and effective non-opioid medication availability, and a robust pipeline in the market.
Lack of awareness among common people leads to a preference for alternative therapies, and the market has an abundance of counterfeit products. Even non-opioid drugs do not show long term efficiency as required. These are the common factors hampering the market growth.
Market Segmentation:
By Drug Type
• NSAIDs
• Corticosteriods
• Medical Cannabis Treatment
• Menthol-Containing Treatment
• Others
By Application
• Orthopedic and Musculoskeletal Pain
• Neuropathic Pain
• Cancer Pain
• Other Pain
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Aphria Inc*
• Aurora
• Bedrocan
• Canopy Growth Corp.
• Cara Therapeutics
• Centrexion Therapeutics
• Others
View full report: https://www.datamintelligence.com/research-report/non-opioid-pain-treatment-market
Download free sample: https://www.datamintelligence.com/download-sample/non-opioid-pain-treatment-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Types of pain include chronic headaches, back pain, pain associated with surgery or treatments, sports injuries, and accidents. Every year, millions of prescriptions are written for pain medications, out of which many are powerful opioids that can cause side effects and lead to addiction.
The market is currently gradually inclining towards the adoption of non-opioid medications to overcome the addiction toward opioids and certain well-established painkillers in the market. But there are many non-opioid treatments available for pain such as over-the-counter aspirin, ibuprofen, and acetaminophen, but some of them such as Celebrex, Cataflam, and Motrin, are prescription only drugs.
Market Dynamics:
The market is driven by rising geriatric population, rise in incidences of chronic pain, increase in the opioid misuse, easy and effective non-opioid medication availability, and a robust pipeline in the market.
Lack of awareness among common people leads to a preference for alternative therapies, and the market has an abundance of counterfeit products. Even non-opioid drugs do not show long term efficiency as required. These are the common factors hampering the market growth.
Market Segmentation:
By Drug Type
• NSAIDs
• Corticosteriods
• Medical Cannabis Treatment
• Menthol-Containing Treatment
• Others
By Application
• Orthopedic and Musculoskeletal Pain
• Neuropathic Pain
• Cancer Pain
• Other Pain
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Aphria Inc*
• Aurora
• Bedrocan
• Canopy Growth Corp.
• Cara Therapeutics
• Centrexion Therapeutics
• Others
View full report: https://www.datamintelligence.com/research-report/non-opioid-pain-treatment-market
Download free sample: https://www.datamintelligence.com/download-sample/non-opioid-pain-treatment-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results